Pfizer Ltd.
BSE: 500680 | Sector: Health care |
NSE: PFIZER | ISIN Code: INE182A01018 |
BSE 00:00 | 26 Feb | 4550.70 |
-19.85 (-0.43%) |
OPEN
4510.00 |
HIGH
4565.00 |
LOW
4481.60 |
NSE 00:00 | 26 Feb | 4551.75 |
-7.85 (-0.17%) |
OPEN
4500.00 |
HIGH
4568.00 |
LOW
4478.80 |
OPEN | 4510.00 |
PREVIOUS CLOSE | 4570.55 |
VOLUME | 5583 |
52-Week high | 5875.00 |
52-Week low | 3588.15 |
P/E | 41.63 |
Mkt Cap.(Rs cr) | 20,819 |
Buy Price | 4550.70 |
Buy Qty | 4.00 |
Sell Price | 4560.00 |
Sell Qty | 18.00 |
About Pfizer Ltd.
Pfizer Limited is engaged in manufacturing marketing trading and export of pharmaceutical products. The company is a subsidiary of Pfizer Inc. the world's premiere biopharmaceutical corporation with annual revenues of $52.5 billion in 2017. Pfizer Limited has a portfolio of over 150 products across 15 therapeutic areas. Its top brands include Prevenar 13 Lyrica Eliquis Enbrel Becosules Gelusil and...> More
Pfizer Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
20,819 | |
EPS - TTM | (![]() |
[*S] | 109.31 |
P/E Ratio | (X) | [*S] | 41.63 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | 100.00 | |
Latest Dividend Date | 27 Aug 2020 | ||
Dividend Yield | (%) | 7.25 | |
Book Value / Share | (![]() |
[*S] | 468.23 |
P/B Ratio | (![]() |
[*S] | 9.72 |
News
-
Pfizer wants India to order Covid-19 vaccine before pursuing nod
-
Pfizer compiling data to answer DCGI queries on coronavirus vaccine
-
Adani Ports, Bajaj Finance: These 62 stocks in Nifty500 promise smart gains
-
Pfizer working on cold storage issues to ensure temperature integrity
-
We can stop Covid-19: Moderna vaccine success gives world more hope
Announcement
-
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) R
-
Unaudited Financial Results For The Quarter Ended December 31 2020.
-
Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended
-
Statement Of Investor Complaints For The Quarter Ended December 2020
Pfizer Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 593.49 | 538.18 | 10.28 |
Other Income | 14.57 | 58.22 | -74.97 |
Total Income | 608.06 | 596.4 | 1.96 |
Total Expenses | 396.72 | 404.74 | -1.98 |
Operating Profit | 211.34 | 191.66 | 10.27 |
Net Profit | 141.24 | 139.06 | 1.57 |
Equity Capital | 45.75 | 45.75 | - |
Pfizer Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Glaxosmi. Pharma | 1460.70 | -0.77 | 24745.72 |
Ipca Labs. | 1849.30 | -0.87 | 23458.37 |
Syngene Intl. | 558.85 | -0.61 | 22354.00 |
Pfizer | 4550.70 | -0.43 | 20819.45 |
Sanofi India | 8268.85 | 1.40 | 19043.16 |
Alembic Pharma | 919.15 | 2.38 | 18065.89 |
Ajanta Pharma | 1747.50 | -0.04 | 15124.61 |
Pfizer Ltd - SHAREHOLDING PATTERN
|
|
Pfizer Ltd - Research Reports
Date | Broker | Action | Price | Report |
15/07/2020 | Centrum Broking | Buy | 4133 | ![]() |
16/06/2020 | ICICI Securities | Buy | 4078 | ![]() |
Pfizer Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 0.80% | 0.60% | -3.52% | -3.02% |
1 Month | -3.63% | -3.59% | 1.56% | 2.04% |
3 Month | -11.12% | -11.10% | 10.94% | 11.87% |
6 Month | -6.31% | -6.19% | 25.66% | 25.80% |
1 Year | 8.55% | 8.68% | 23.09% | 24.41% |
3 Year | 99.09% | 98.73% | 42.54% | 37.29% |
Pfizer Ltd - STOCK STRENGTH
Today's Low/High | 4481.60 | 4565.00 | |
Week Low/High | 4200.00 | 4620.00 | |
Month Low/High | 4200.00 | 4813.00 | |
YEAR Low/High | 3588.15 | 5875.00 | |
All TIME Low/High | 25.00 | 5875.00 |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices